Stephen Edge, MD, FACS

PrintE-mail
Alfiero Foundation Endowed Chair in Breast Oncology
Medical Director, Breast Center
Chief of Breast Surgery
Department of Surgical Oncology
Chair, Health Services and Outcomes Research
Roswell Park Cancer Institute
Professor of Surgery
School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Profile

Areas of Expertise: 
Breast Cancer

Research

Research Interests: 
Diagnosis, staging and treatment of breast cancer
Health services research, including how cancer care is delivered
Mechanisms to evaluate and improve cancer care and outcomes

Background Information

Education and Training: 
MD - Case Western Reserve University Medical School, Cleveland, OH
BA - Tufts University, Medford, MA
Residency: 
University Hospitals of Cleveland, Cleveland, OH
Board Certification: 
Surgery, American Board of Surgery
Fellowships: 
National Cancer Institute, Bethesda, MD

Publications

Publications: 
  • Alderman AK, Niland JC, Weeks JC, Wong Y-N, Theriault RL, Ottesen RA, Hughes ME, Schott A, Collins ED, Edge SB. The impact of breast reconstruction on the delivery of chemotherapy. Cancer 2010; 116(7):1791-1800
  • Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 2010; 17(6):1471-1474
  • McCann SE, Kasprzak C, Li H-F, Edge SB, Ambrosone CB, Shields PG, Trevisan M, Dorn J, Nie J, Thompson LU, Freudenheim JL. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast cancer research and treatment 2010; 122(1):229-235
  • Meguerditchian A-N, Stewart A, Roistacher J, Watroba N, Cropp M, Edge SB. Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer. Journal of surgical oncology 2010; 101(7):593-599
  • Platek ME, Winston J, Edge SB, Nochajski TH, Russell M, Trevisan M, Millen AE, Ambrosone C, Wilding GE, Nie J, McCann SE, Bonner MR, Marian C, Tan D, Shields PG, Freudenheim JL. Alcohol consumption and breast tumor mitochondrial DNA mutations. Breast cancer research and treatment 2010; 121(2):453-460
  • Brasky TM, Shields PG, Trevisan M, Marian C, Kallakury BVS, Edge SB, Tao MH, Nie J, Ambrosone CB, Moysich KB, Bonner MR, Freudenheim JL. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer causes and control : CCC 2010; 21(9):1503-1512
  • Edge SB. Commentary: "help the doctor"-the culture shift to 21st century care management. Journal of oncology practice 2010; 6(2):89-90
  • Fedewa SA, Ward EM, Stewart AK, Edge SB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. Journal of clinical oncology 2010; 28(27):4135-4141
  • Garber JE, Shahab N, Levine E, Winer E, Scalzo A, Orcutt J, Kimmick G, Paskett EM, Dressler L, Shapiro CL, Edge S, Atkins JN, Archer L, Kaplan E, Tolaney SM, Halabi S, Berliner N. Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. Journal of the National Cancer Institute 2010; 102(13):942-949
  • Hong C-C, Kokolus K, Ambrosone C, Edge S, Kulkarni S, Repasky E. Body temperature and thermal discomfort among breast cancer survivors. Proceedings of the American Association for Cancer Research Annual Meeting 2010; 51:218
  • Mandelblatt JS, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H, Barry WT, Tallarico M, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Cancer Leukemia Group B. Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. Journal of clinical oncology 2010; 28(19):3146-3153
  • Cox DD, Miller A, Edge S, Kuvshinoff B. Regionalization of pancreatic resection for malignancy in NY State and the effect of hospital volume on perioperative mortality. Annals of surgical oncology 2010; 17(Suppl. 1):S80
  • Kanchira K, Zakharia Y, Tan W, Liu W, Wilding G, Edge S, Tan D, Khoury T. Frozen section versus touch preparation for intraoperative detection of sentinel lymph node metastases from breast cancer: A single institution experience of 396 cases. Laboratory investigation 2010; 90(Suppl. 1):54A
  • Khoury T, Zakharia Y, Hwang H, Liu W, Edge S, Tan D, Morrison C. HER2 testing: How to get high concordance rate between immunohistochemistry and fluorescence in situ hybridization. Laboratory investigation 2010; 90(Suppl. 1):56A
  • Lillard S, Watroba N, Miller A, Kulkarni S, Edge S. Early stage breast cancer in elderly women - Can radiation therapy safely be withheld outside of a clinical trial setting?. Annals of surgical oncology 2010; 17(Suppl. 1):S54
  • Liu W, Zakharia Y, Tan W, Wilding G, Edge S, Tan D, Khoury T. Intraoperative detection of sentinel lymph node metastases from breast cancer: Does the pathologist experience, subspecialty or the surgeon experience matter?. Laboratory investigation 2010; 90(Suppl. 1):59A
  • Wilson JP, Edge S. Breast education in residency. Annals of surgical oncology 2010; 17(Suppl. 1):S60
  • Zhang S, Zakharia Y, Tan W, Wilding G, Edge S, Liu W, Tan D, Khoury T. Breast hormonal receptors test should be repeated on excisional biopsies after negative core biopsy. Laboratory investigation 2010; 90(Suppl. 1):80A
  • Ahn HS , Lee H-J , Hahn S , Kim W-H , Lee KU , Sano T , Edge SB , Yang H-K. Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer 2010; 116(24):5592-5598
  • Carlson RW , Ljung BM , Marcom PK , Mayer IA , McCormick B , Pierce LJ , Reed EC , Smith ML , Som G , Topham NS , Ward JH , Winer EP , Hudis CA , Hayes DF , Allred DC , Anderson BO , Burstein HJ , Carter WB , Edge SB , Erban JK , Farrar WB , Forero A , Giordano SH , Goldstein LJ , Gradishar WJ , Wolff AC. Breast cancer: noninvasive and special situations. Journal of the National Comprehensive Cancer Network : JNCCN 2010; 8(10):1182-1207
  • Edge SB , Zwelling LA , Hohn DC. The anticipated and unintended consequences of the patient protection and affordable care act on cancer research. Cancer journal (Sudbury, Mass.) 2010; 16(6):606-613
  • Brasky TM, Shields PG, Trevisan M, Edge SB, Tao MH, Nie J, Ambrosone CB, Marian C, Ochs-Balcom HM, Moysich KB, Bonner MR, Freudenheim JL. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast cancer research and treatment 2011; 126(1):157-165
  • Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W 3rd. Breast cancer racial disparities: unanswered questions. Cancer research 2011; 71(3):640-644
  • Ademuyiwa FO, Miller A, Edge SB, Thorat MA, Sledge GW, Badve SS. The effects of Oncotype DX recurrence scores on chemotherapy receipt in a multi-institutional breast cancer cohort. Journal of clinical oncology 2010; 28(15 Suppl.):669
  • Edge SB, Blumenthal WJ, Barron J, Singer J, Walczak DE, Newcomer LN, Stewart A, Palis BE, Mallin K, Warther BL. State-wide application of breast and colon cancer quality measures (QMs) using linked claims and registry data. Journal of clinical oncology 2010; 28(15 Suppl.):6004
  • Partridge AH, Weeks JC, Winer EP, Niland JC, Blayney DW, Theriault RL, Edge SB, Wong Y, Hughes ME, Tamimi RM. The effect of age on delay in diagnosis and stage of breast cancer. Journal of clinical oncology 2010; 28(15 Suppl.):1580
  • Edge SB. Nipple-sparing mastectomy: how often is the nipple involved?. Journal of clinical oncology 2009; 27(30):4930-4932
  • Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer 2009; 115(4):716-724
  • Lehman CD, DeMartini W, Anderson BO, Edge SB. Indications for breast MRI in the patient with newly diagnosed breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2009; 7(2):193-201
  • McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 2009; 115(23):5404-5412
  • Tao MH, Trevisan M, Vito D, Winston J, Edge SB, Xie B, Krishnan SS, Platek M, McCann SE, Ambrosone CB, Marian C, Nie J, Shields PG, Freudenheim JL. DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer epidemiology, biomarkers and prevention 2009; 18(3):998-1002
  • Platek ME, Edge SB, Nochajski TH, Russell M, Trevisan M, Quick SK, Ochs-Balcom HM, Millen AE, Ambrosone CB, Nie J, Bonner MR, McCann SE, Marian C, Shields PG, Freudenheim JL. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer epidemiology, biomarkers and prevention 2009; 18(9):2453-2459
  • Svahn TH, Bookman MA, Schott AF, Edge SB, Theriault RL, Ottesen RA, Hughes ME, Carlson RW, Niland JC, Weeks JC. Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2009; 7(2):115-121
  • Tao MH, Trevisan M, Vito D, Winston J, Xie B, Marian C, Krishnan SS, Edge SB, Ambrosone CB, Millen A, Nie J, Shields PG, Freudenheim JL. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast cancer research and treatment 2009; 114(3):559-568
  • Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. International journal of radiation oncology, biology, physics 2009; 73(4):997-1002
  • Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S. The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast cancer research and treatment 2011; 126(3):797-802
  • Carlson RW, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Ljung B-M, Hudis CA, Hayes DF, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Zellars R. Invasive breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2011; 9(2):136-222
  • Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). Journal of health care for the poor and underserved 2011; 22(1):128-141
  • Khoury T, Zakharia Y, Tan W, Kulkarni S, Liu W, Zhang S, Wilding GE, Edge S. Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Breast journal 2011; 17(2):180-186
  • Wasif N, Bleznak A, Marcus SG, Kollmorgen D, Anthony T, Wong SL, Edge SB, McCahill LE, Ko CY, Cormier JN, Leong SPL. Quality measurement in cancer care delivery. Annals of surgical oncology 2011; 18(3):611-618
  • Wilson JP , Mattson D , Edge SB. Is there a need for axillary dissection in breast cancer? . Journal of the National Comprehensive Cancer Network : JNCCN 2011; 9(2):225-230
  • Yao S, O'Connor TL, Edge SB, Kulkarni S, Hwang H, McCann SE, Hong C-C, Davis W, Nesline MK, Trump DL, Johnson CS, Millen AE, Sucheston LE, Ambrosone CB. Pretreatment serum concentrations of 25-hydroxyvitamin d and breast cancer prognostic characteristics: a case-control and a case-series study. PloS one 2011; 6(2):e17251
  • Brasky TM, Shields PG, Trevisan M, Goerlitz DS, Marian C, Kallakury BV, Edge SB, Tao MH, Nie J, Ambrosone CB, Moysich KB, Bonner MR, Freudenheim JL. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer causes and control : CCC 2011; 22(7):965-975
  • Erwin DP, Erwin DO, Ciupak G, Hellenthal N, Sofi MJ, Guru KA, Edge SB. Challenges and implementation of a women's breast health initiative in rural Kashmir. Breast (Edinburgh, Scotland) 2011; 20(Suppl. 2):S46-S50
  • Marian C, Ochs-Balcom HM, Nie J, Kallakury BV, Ambrosone CB, Trevisan M, Edge S, Shields PG, Freudenheim JL. FGFR2 intronic SNPs and breast cancer risk: Associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. International journal of cancer 2011; 129(3):702-712
  • Wong YN, Ottesen RA, Hughes ME, Niland JC, Theriault R, Edge SB, Blayney D, Weeks JC. Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence? . Oncologist 2011; 16(5):559-565
  • Desch CE, Stewart AK, Ko CY, Weeks JC, Kahn KL, Donaldson MS, Lepisto E, McClure J, Schrag D, Schneider EC, McNiff KK, Edge SB. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. Journal of clinical oncology 2008; 26(21):3631-3637
  • Edge SB. Early adoption and disturbing disparities in sentinel node biopsy in breast cancer. Journal of the National Cancer Institute 2008; 100(7):449-450
  • Hassett MJ, Blayney DW, Carter WB, Wilson J, Wong YN, Theriault RL, Edge SB, Niland JC, Hughes ME, Weeks JC. Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. Journal of clinical oncology 2008; 26(34):5553-5560
  • Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Medical care 2008; 46(8):762-770
  • Bilimoria KY, Stewart AK, Edge SB, Ko CY. Lymph node examination rate, survival rate, and quality of care in colon cancer. JAMA : the journal of the American Medical Association 2008; 299(8):896; author reply 897-898
  • Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. International journal of radiation oncology, biology, physics 2008; 72(5):1434-1440
  • White JR, Halberg FE, Rabinovitch R, Green S, Haffty BG, Solin LJ, Strom EA, Taylor ME, Edge SB. American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma. Journal of the American College of Radiology : JACR 2008; 5(6):701-713
  • Wong SL, Leong SP, Petrelli NJ, Anthony T, Kollmorgen DR, Beitsch PD, Askew RL, Edge SB, McCahill LE, Cormier JN. Getting to better cancer care: results of a society of surgical oncology survey. Annals of surgical oncology 2008; 15(9):2363-2371
  • Carlson RW, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Marks LB, Kiel K, Ljung BM, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Wolff AC. Invasive breast cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2007; 5(3):246-312
  • Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Broffman G, Fox CH, Mahoney MC, Edge SB. Linked claims and medical records for cancer case management : evaluation of mammography abnormalities. Cancer 2007; 110(3):518-524
  • Fernando SA, Edge SB. Evidence and controversies in the use of post-mastectomy radiation. Journal of the National Comprehensive Cancer Network : JNCCN 2007; 5(3):331-338
  • McCann SE, McCann WE, Hong CC, Marshall JR, Edge SB, Trevisan M, Muti P, Freudenheim JL. Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study. American journal of clinical nutrition 2007; 86(2):465-471
  • Yen TWF, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC. Impact of randomized clinical trial results in the National Comprehensive Cancer Network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. Journal of clinical oncology 2007; 25(22):3251-3258
  • Nie J, Edge SB, Trevisan M, Muti P, Vito D, Rogerson P, Vena JE, Han D, Bonner MR, Beyea J, Freudenheim JL. Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer causes and control : CCC 2007; 18(9):947-955
  • Quick SK, Muti P, Marian C, Edge SB, Seddon M, Lehman TA, Modali R, Vito D, Trevisan M, Hutson AD, McCann SE, Platek ME, Nie J, Shields PG, Freudenheim JL. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer epidemiology, biomarkers and prevention 2008; 17(5):1082-1087
  • Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB. Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer 2011; 117(18):4132-4140
  • Dominici L, Burstein H, Edge S, Javid S, Carter B, Wong Y-N, Marcom P, Niland J, Hughes M, Najita J, Golshan M. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast cancer research and treatment 2011; 129(2):459-465
  • Greenberg CC, Niland J, Blayney DW, Carter WB, Wilson JL, Theriault R, Edge SB, Hughes ME, Lipsitz SR, Weeks JC. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Annals of surgery 2011; 254(2):339-345
  • Khoury T, Kulkarni S, Morrison C, Bshara W, Zakharia Y, Edge S. HER2 Testing: How to Reach a High Concordance Rate Between Immunohistochemistry and Fluorescence In Situ Hybridization. Applied immunohistochemistry and molecular morphology : AIMM 2011; 19(5):424-430
  • Roberts MR, Edge SB, Trevisan M, Amend KL, Lehman T, Seddon M, Modali R, Goerlitz DS, Krishnan SS, Marian C, Nie J, Ambrosone CB, Shields PG, Freudenheim JL. Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011; 32(8):1223-1230
  • Tao MH, Marian C, Nie J, Ambrosone C, Krishnan SS, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. American journal of clinical nutrition 2011; 94(3):831-838
  • Hong CC, Ambrosone C, Ceacareanu A, Wintrob Z, Kokolus K, Davis W, Bovbjerg DH, Jenkins FJ, Edge S, Kulkarni S, O'Connor T. Changes in circulating hormone levels and weight among women with early stage breast cancer. American journal of epidemiology 2011; 173(Suppl. 11):S257
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong Y, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):1042
  • Edge SB, Gress D, Winchester DP, Stewart A. A national evaluation of response and factors affecting response to neoadjuvant therapy in breast and rectal cancer : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):6091
  • Francescutti V, Watroba NL, Edge SB. Concordance with NCCN practice guidelines for local therapies as a measure of quality of care: Review of practice and identification of quality gaps : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):6019
  • Brewster AM, Etzel C, Zhou R, Wong Y, Edge SB, Blayney DW, Wilson J, Hudis C, Weeks JC, Theriault RL. The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer. Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #6517
  • Hughes ME, Ottesen R, Niland JC, Edge SB, Theriault RL, Wilson J, Blayney DW, Wong Y, Weeks JC. Quality of breast cancer care in NCCN centers as assessed by the ASCO/NCCN quality measures: Overall performance and reasons for nonconcordance. Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #6506
  • Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong Y, Blayney DW, Niland JC, Winer EP, Weeks JC. Clinicopathological features and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN). Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #543
  • McCann SE, Nie J, Dorn J, Trevisan M, Millen AE, Shields PG, Schelske-Santos M, Ambrosone CB, Marian C, Vito D, Edge SB, Freudenheim JL. Dietary lignan intakes and survival in women with breast cancer in the Western New York Exposures and Breast Cancer (WEB) Study. Proceedings of the American Association for Cancer Research Annual Meeting 2008; 49:991
  • Meguerditchian A, Huang H, Pak Y, Sossey-Alaoui K, Watroba N, Hutson A, Kulkarni S, Edge SB, Geradts J, Coignet LJ. CD24/FLJ 13639 expression ratio predicts worse outcome in invasive breast cancer. Annals of surgical oncology 2007; 14(2 Suppl.):35
  • Meguerditchian AN, Watroba N, Roistacher J, Stewart A, Cropp M, Edge SB. Administrative claims: a novel approach in monitoring long term adherence to anti-hormonal therapy in breast cancer. Cancer research 2009; 69(2 Suppl.):146S-147S
  • O'Connor T, Houde C, Dolce J, Bundy B, Nesline M, Davis W, Ambrosone C, Levine E, Edge SB, Coignet LJ. The presence of the FRA12E/SMRT fragile site in the genome of breast cancer (BC) patients is a predictor of metastatic development. Breast cancer research and treatment 2007; 106(Suppl. 1):S170-S171
  • Roberts M, Shields PG, Ambrosone CB, Nie J, Marian C, Amend KL, Trevisan M, Edge SB, Freudenheim JL. DNA repair gene single nucleotide polymorphisms and risk of breast cancer (WEB study). Proceedings of the American Association for Cancer Research Annual Meeting 2009; 50:953-954
  • Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong Y, Loftus LS, Breslin TM, Hudis C, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC. Timing in adjuvant chemotherapy (CTX) initiation among women with breast cancer (BC) at National Comprehensive Cancer Network (NCCN) centers: An analysis from the NCCN Outcomes Database : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):6022
  • Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast cancer research and treatment 2011; 130(3):897-904
  • Lally RM, Hydeman JA, Schwert K, Henderson H, Edge SB. Exploring the first days of adjustment to cancer: a modification of acclimating to breast cancer theory. Cancer nursing 2012; 35(1):3-18
  • Tao MH, Marian C, Shields PG, Nie J, McCann SE, Millen A, Ambrosone C, Hutson A, Edge SB, Krishnan SS, Xie B, Winston J, Vito D, Russell M, Nochajski TH, Trevisan M, Freudenheim JL. Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol (Fayetteville, N.Y.) 2011; 45(7):689-699
  • Tao M-H, Mason JB, Marian C, McCann SE, Platek ME, Millen A, Ambrosone C, Edge SB, Krishnan SS, Trevisan M, Shields PG, Freudenheim JL. Promoter methylation of E-cadherin, p16, and RAR-beta(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism. Nutrition and cancer 2011; 63(7):1143-1150
  • Ricks-Santi LJ, Sucheston LE, Yang Y, Freudenheim JL, Isaacs CJ, Schwartz MD, Dumitrescu RG, Marian C, Nie J, Vito D, Edge SB, Shields PG. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC cancer 2011; 11 :278
  • Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL. Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer epidemiology, biomarkers and prevention 2012; 21(1):239-242
  • McCann SE, Hootman KC, Weaver AM, Thompson LU, Morrison C, Hwang H, Edge SB, Ambrosone CB, Horvath PJ, Kulkarni SA. Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. Journal of nutrition 2012; 142(1):91-98
  • Wilson JP, Miller A, Edge SB. Breast education in general surgery residency. American surgeon 2012; 78(1):42-45
  • Dhillon J, Edge S, Kasznica J, Nava ME, Ankola A, Ademuyiwa F. Importance of biopsy of a presumed solitary skeletal metastasis: enchondroma in a breast cancer patient. Breast journal 2012; 18(2):172-174
  • Dobson KA, Freudenheim JL, Shields PG, Tao MH, Marian C, Nie J, Edge SB, Winston JS, Trevisan M, Bonner MR. Air pollution exposure and promoter methylation of E-cadherin, p16, and RAR-β in breast cancer tumors from cases in the WEB study. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #5610
  • Roberts M, Hong C-C, Edge S, Yao S, Nesline M, Ambrosone CB. Polymorphisms in metastasis suppressor genes (BRMS1 and SIPA1): Breast tumor characteristics and lymph node metastasis. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #5595
  • Edge SB. True patriotism: a generation of commitment to quality in the Veterans Health Administration. Journal of clinical oncology 2012; 30(10):1027-1029
  • Ademuyiwa FO, Bshara W, Attwood K, Edge SB, Ambrosone CB, Morrison CD, Ritter G, Miliotto A, Gnjatic S, Odunsi K. Immunogenicity of NY-ESO-1 cancer testis antigen in triple-negative breast cancer. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e11563
  • Jones NB, Ottesen RA, Niland JC, Breslin TM, Weeks JC, Hughes ME, Agnese DM, Edge SB. Overuse of sentinel lymph node biopsy with breast conserving surgery for clinical DCIS. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #1125
  • McNamara EJ, Stewart A, Gay EG, Banasiak J, Eremin D, Harman D, Flores R, Edge SB. Beyond the performance rate: Understanding differences in treatment status using the Rapid Quality Reporting System (RQRS). Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #6088
  • Yao K, Czechura T, Huo D, Winchester DP, Edge SB, Winchester DJ. Utilization of post-lumpectomy radiation therapy in women 70 years of age or older: A report from the National Cancer Data Base. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #1033
  • Ahmed AA, Ngamphaiboon N, Kossoff E, Meagher A, Attwood K, Edge SB, Ademuyiwa FO. Impact of patient characteristics on compliance to adjuvant chemotherapy in hormone receptor negative breast cancer: A single institution experience : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e19568
  • Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong Y-N, Vandergrift JL, Niland JC, Weeks JC. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. Journal of clinical oncology 2012; 30(18):2218-2226
  • Ademuyiwa FO, Bshara W, Attwood K, Morrison C, 4533, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K. NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer. PloS one 2012; 7(6):e38783
  • Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung B-ME, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : JNCCN 2012; 10(7):821-829
  • O'Connor TL, Edge SB, Kossoff EB, Groman A, Wilding GE, Ademuyiwa FO, Levine EG, Watroba N, Ngamphaiboon N. Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer. Journal of geriatric oncology 2012; 3(4):320-328
  • Partridge AH, Hughes ME, Ottesen RA, Wong Y-N, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 2012; 17(6):775-782